Nasdaq Stockholm

Oncopeptides AB

ISIN SE0009414576Filings at the FI

At a glance

Most recent filing on June 9, 2026 — a grant by Christine Elizabeth Rankin on Jun 9, 2026.

We hold 91 visible filings, going back to February 21, 2017.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 91 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 91. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Christine Elizabeth Rankin Board member
59,897 sharesGrant
TradedJun 9, 2026FiledJun 9, 2026
Per Wold-Olsen Chair of the board
149,743 sharesGrant
TradedJun 9, 2026FiledJun 9, 2026
Stefan Norin Other member of the administrative, management or supervisory body
4,650 SEKGrant
TradedMar 19, 2026FiledMar 20, 2026
Christine Elizabeth Rankin Board member
23,775 SEKOpen-market buy
TradedMar 17, 2026FiledMar 18, 2026
Per Wold-Olsen Chair of the board
254,311 sharesGrant
TradedOct 17, 2025FiledOct 17, 2025

Short positions

All short positions

Net short positions of 0.5% or more in Oncopeptides AB that are open today, as the regulator publishes them. Together they come to 1.48% of the shares. Positions below 0.5% are not published, so the real total can be higher.

2 open positions, together 1.48%. The holders and their history are part of the subscription.

Källa: Finansinspektionen, October 31, 2026.